Cecilia Fosser is Director, Quantitative Pharmacology and Pharmacometrics, at Cytel. She combines statistical and pharmacometrics techniques to develop advanced approaches for quantitative drug development. Her experience includes Phases 1–4 of clinical trial development and spans a range of therapeutic areas. In the past, she has worked with Pfizer’s Pharmacometrics Group, with a focus on inflammation.
Her publications include work on exposure-response analyses of multiple endpoints. She has delivered presentations at several large international conferences such as ASCPT and ACoP. Cecilia obtained a PhD in Applied Mathematics from the University of Arizona.